Impact of pharmacist intervention in patient counseling at point of hospital discharge in a specialized cardiac center in Saudi Arabia by Assiri, Turki et al.
Assiri et al 
Trop J Pharm Res, May 2017; 16(5): 1187  
 
Tropical Journal of Pharmaceutical Research May 2017; 16 (5): 1187-1193 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v16i5.29 
Original Research Article 
 
 
Impact of pharmacist intervention in patient counseling at 
point of hospital discharge in a specialized cardiac center 
in Saudi Arabia 
 
Turki Assiri1*, Fowad Khurshid2, Meshal Almutairi1, Mona Alhusayyen1, Fahad 
Alkharji1, Mohammed Alsultan2 
1Department of Pharmacy, Prince Sultan Cardiac Center, 2Pharmacoeconomics and Outcomes Research Unit, Department of 
Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia 
 
*For correspondence: Email: Tassiri@pscc.med.sa; Tel: +966-11478-3000 
 
Sent for review: 20 September 2016        Revised accepted: 18 April 2017 
 
Abstract 
Purpose: To determine the interventions associated with the pharmacist’s patient counseling and 
review of discharge prescriptions of patients from a specialized cardiac center in Saudi Arabia. 
Methods: This was a prospective interventional study conducted at Prince Sultan Cardiac Center 
(PSCC) in Riyadh, Saudi Arabia for a duration of 12 months. The pharmacist responsible for providing 
patient counseling reviewed the patient records, collected patient demographics and clinical data, as 
well as medical and medication history, diagnosis and discharge (treatment) plan.  
Results: The study included 2008 patients who met the inclusion criteria. The counseling pharmacist 
identified and provided interventions to 358 (18 %) patients for 508 (3.4 %) items. About half of 
counseling pharmacist interventions concerned involved the addition of a drug to treatment regimen 
followed by drug discontinuation (28.1 %). The most common reason for adding the drug during patient 
counseling was the omission of medications (35 %). Angiotensin-converting enzyme 
inhibitors/angiotensin receptor blockers (ACEI/ARBs), antidiabetics and antihyperlipidemics were the 
classes of drugs often associated with counseling pharmacist interventions. The cost-saving 
interventions identified were 200 (39.4 %). Out of these, drug discontinuation (n = 143) was the most 
frequent suggestion provided by the intervening pharmacist, followed by a dose reduction resulting in 
cost savings of 66.5 % (US $ 6,590.10) and 8.9 % (US $ 882.32), respectively. 
Conclusion: The results indicate that discharge medication discrepancies decrease as a result of 
pharmacist-facilitated patient counseling at the point of hospital discharge.  
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Medication discrepancies at the point of hospital 
discharge are a common occurrence [1-3]. A 
recent study reported that 41.3 % of patients had 
at least one inadvertent medication discrepancy 
at hospital discharge, and 55.3 % were at risk for 
possible unintentional discrepancies [3]. In 
addition, a randomized controlled trial among 
851 discharged cardiac patients concluded that 
half of the patients (50.8 %) experienced 
clinically important medication errors after 
hospital discharge and 22.9 % of such errors 
classified to be serious [4]. Also, a Canadian 
study reported that nearly 23 % of patients 
experienced at least one adverse event after 
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hospital discharge and 72 % of which related to 
medications [5].  
 
Structured patient counseling and medication 
reconciliation at the time of hospital discharge 
may help to prevent these discrepancies [3]. 
Global studies conclude that providing 
information at the time of hospital discharge to 
patients and post discharge support decreases 
the number of readmissions and advance the 
patient’s quality of life [6-8]. Also, in a study, Al-
Rashed et al. [9] concluded that pre-discharge 
counseling provided with improved drug 
information and compliance together with 
reduced re­admissions and unplanned visits to 
the physician. A study conducted at a teaching 
hospital among patients being discharged home 
from the hospital concluded that a reasonably 
lower rate of preventable adverse drug events 
occurred after medication review and discharge 
counseling by pharmacists [10]. Another study in 
a tertiary hospital in Saudi Arabia concluded that 
implementation of the patient counseling 
program to discharge patients reduced adverse 
drug events from 24 to 2.3 % [11]. 
 
The studies related to the impact of pharmacist’s 
interventions in patient counseling prior to 
hospital discharge in Saudi Arabia are limited. 
This study aimed to determine the impact of 
pharmacist’s counseling and review of discharge 
prescriptions for patients discharged from a 
specialized cardiac center in Saudi Arabia. Also, 
we examined the potential financial impact that 
could result from implementation of counseling 





This was a prospective interventional study 
conducted at Prince Sultan Cardiac Center 
(PSCC) in Riyadh, Saudi Arabia for 12 months 
duration (January to December 2012).  PSCC is 
a specialized healthcare center provides 
comprehensive cardiovascular services to all 
armed forces personnel, their dependents, and 
other patients referred to the center for further 
evaluation and specialized treatment and include 
about 190 beds dedicated to adult and pediatric 
cardiac patients. The study included all 
discharged adult cardiac patients of either sex 
from adult cardiology wards, including Day-Case 
post catheterization patients and coronary care 
unit patients. Exclusion criteria were adult 
cardiac surgery patients, pediatric patients, 
patient discharged without medication, 
transferred patients (to another ward or another 
care facility), patients with cognitive defect, the 
patient discharged without patient counseling, 
patient who received patient counseling from 
staff other than a pharmacist, patient who 
rejected patient counseling and lastly, patients 
with incomplete patient demographic/clinical 
data. This study was carried out in accordance 
with the Declaration of Helsinki [12], and Good 
Clinical Practice guideline [13]. The pharmacy 
administration and research department of the 
hospital reviewed and approved the study (ref 
no. R&EC03.1.acv).  
 
After the processing of discharged medications 
and once the medication was available in the 
ward, the assigned nurse received and checked 
the medications before contacting patient 
counseling pharmacist to provide medication 
counseling to discharge patients. With each plan 
of discharge, the pharmacist responsible for 
providing patient counseling reviewed the patient 
record, identified patient demographics and 
clinical data, medical and medication history, 
diagnosis and discharge (treatment) plan. The 
pharmacist counseling the patients handled the 
review of the discharge medication and 
correction of any discrepancy before starting and 
during a patient counseling session. After 
completing the session, the pharmacist 
documented any discrepancy encountered. The 
pharmacist also required to resolve these 
discrepancies by contacting the assigned ward 
clinical pharmacist or treating physician and 
document that intervention in the patient's file 
and patient counseling form. The intervention 
considered in this study was defined as “any 
action by a pharmacist that directly resulted in a 




The direct medication cost saving calculated, for 
interventions that cause discontinuation of 
medication due to inappropriate use (e.g., 
duplicate therapy, lack of indication, errors, and 
drug interactions); medication dose reduction, 
duration or frequency adjustment; or substitution 
of less expensive alternative (e.g., oral vs. 
intravenous route of administrations). With 
patient discharge medications, the cost savings 
for the whole prescribed periods (about 3 
months) were calculated because the 
intervention will most probably not to take place 
until the patient's next visit to a refill or an 
appointment. Direct medication cost savings 
calculated by multiplying the medication's 
average annual unit acquisition price as provided 
by the supply department - times the number of 
total daily doses and the number of days 
reduced.  The results expressed in US Dollars 
(US $). Annual cost savings calculated by 
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extrapolating the net cost savings made during 
the 3 months to over 1 year. 
 
Statistical Package for the Social Sciences 
(SPSS) version 20 (SPSS Inc., Chicago, IL, 
USA) used for descriptive statistical analysis. 
The data are summarized using descriptive 
statistics and categorical variables expressed as 




This study included 2008 patients who met the 
inclusion criteria. The characteristics of these 
patients are presented in Table 1. 
 






Male 1410 70.2 
Female 598 29.8 
Age (year, mean ± SD)       60  (±13) 
< 45 213 10.6 
45-65   1116 55.6 
66-80 602 30.0 
> 80 76 3.8 
Level of education 
None (illiterate) 64 3.2 
Elementary 1224 60.9 
Secondary 636 31.7 
University 84 4.2                  
Diagnosis 
Acute coronary syndrome  
     MI  







CAD 422 21.0 
HF 233 11.6 
V or RHD 222 11.1 
Arrhythmia 179   8.9 
Other 28   1.4 
Risk Factor 
Hypertension 1243 61.9 
Diabetes Mellitus 1120 55.8 
Hyperlipidemia 715 35.6 
Smoking 345 17.2 
Heart failure 340 16.9 




V or RHD 126 6.3 




ACS: Acute Coronary Syndrome; MI: Myocardial 
Infarction; UA: Unstable angina; CAD: Coronary Artery 
Diseases; HF: Heart Failure; V or RHD: 
Valvular/Rheumatic Heart Disease 
 
The study population was predominantly 45-80 
years old (85.6 %). Approximately 70 % of the 
study populations were male and 61 % had an 
elementary education. 
 
Diagnosis and risk factors  
 
Acute coronary syndrome (ACS) was the most 
frequent type of diagnoses, occurring in 46 % of 
the cases, followed by coronary artery diseases 
(21 %) and heart failure (12 %). Over 60 % of 
patients had a history of hypertension, 56 % with 
diabetes mellitus, 44 % with both and 36 % were 
hyperlipidemic. 
 
Pharmacist interventions  
 
During the study period, of 2008 patients, 15087 
prescription items screened and dispensed. The 
average number of items per patient was 8 ± 2. 
Among them, pharmacists provided interventions 
to 358 patients (18 %) for 508 (3.4 %) 
prescription items, with a range over all of one 
intervention for every 4 patients. The average 
daily interventions were 2. Of these, 358 (18 %) 
intervened patients, 247 patients (69 %) had only 
one intervention and 111 (31 %) had more than 
one intervention (Table 2). 
 
Table 2: Intervention analysis 
 
Item Number 
Enrolled patients  2008 
Prescription items screened and 
dispensed 
15087 
Intervention      508* 
Patients without any intervention  1650 
Patients with one intervention      247** 
*This number represents the average of one intervention 
per four patients. **Total number of patients who 
received the intervention is 358 (18% of total patients) 
 
Types of interventions provided during 
patient counseling 
 
The most often provided pharmacist intervention 
was the addition of drug (48 %, n = 244) followed 
by discontinuation of the drug (28 %, n = 143) 
upon the ward clinical pharmacist or treating 
physician approval (Table 3). 
 
Table 3: Types of intervention provided during patient 
counseling 
 
Type of intervention Number (%) 
Addition of drug 244 (48.0) 
Discontinuation of drug 143 (28.1) 
Change in drug dose 75 (14.8) 
Change in frequency of 
administration 
19 (3.7) 
Change in duration of therapy 19 (3.7) 
Other 8 (1.6) 
Total 508 
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Figure 1: Explanation of interventions during patient counseling 
 
The most common reason for adding the drug 
during patient counseling was due to omissions 
of medications (35 %). Prescribing unneeded 
medications (14 %) was the common reason 
associated with drug discontinuation Figure 1. 
 
Class of drugs intervened during patient 
counseling 
 
The majority (15 %; n = 75) of the interventions 
were associated with angiotensin- converting 
enzyme inhibitors/ angiotensin receptor blockers 
(ACEI/ARBs) and antidiabetic drugs followed by 
antihyperlipidemic (10 %; n = 52) and antiplatelet 
(9.5 %; n = 49) Table 4. 
 
Table 4: Class of drugs involved in the intervention 
 
Class of drugs  N  (%) 
ACEI/ARBs 75 15 
Antidiabetic 75 15 
Antihyperlipidemic 52 10 
Antiplatelet 49 9.5 
Beta blocker 42 8 
Calcium channel blocker 29 6 
Diuretic 17 3 
Anticoagulants 13 2.5 
Antiarrhythmic 5 1 
Antibiotics 5 1 
Others 146 29 
Total 508 100 
 
Medication errors identified 
 
About 208 errors documented (41 % of total 
discrepancies) during the study period. 
Pharmacy errors represented 13 % of errors, 
while prescriber errors represented 87 % (Table 
5). 
 













4 (2%) 172 (98%) 176 
Other errors 24 (75%) 8 (25%) 32 




During the study period, the cost saving 
intervention identified were 200 (39.4 %). The 
most frequent intervention provided by the 
intervening pharmacist was drug discontinuation 
(n = 143), resulting in savings of cost US $ 
6,590.1 (66.5 %;) (SAR 3.75 is equal to US $ 1) 
followed by dose reduction US $ 882.3 (8.9 %) 
and duration reduction US $ 868.1 (8.7 %). 
Calculation of the cost saving for pharmacist 
interventions in patient counseling for the 3 
month period resulted in cost saving of US $ 
9,901.6. If the results were extrapolated to the 
whole year, it is estimated that pharmacist 
interventions resulting in a cost-saving of US $ 
39,606.4 and US $ 198.1 per intervention per 




The present study is one of the few studies that 
examine pharmacist-provided patient counseling 
among adult cardiac patients discharged from a 
tertiary care hospital and to the best of our 
knowledge,   it   is   the   first   of   such   studies  
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Table 6: Cost-saving interventions during patient 
counseling program 
 
Type of intervention N Cost/3 mths (US$) 
Discontinuation of drug 143 6,590.1 
Dose reduction 32 882.3 
Duration  reduction 12 868.1 
Frequency reduction 9 827.5 
Others 4 733.6 
Total 200 9901.6 
mths, months; SAR 3.75 is equal to US $ 1 
 
conducted in a specialized cardiac center in 
Saudi Arabia. In this study, counseling 
pharmacist identified and provided interventions 
to 358 (18 %) patients that had medication 
discrepancy in the time of hospital discharge. 
This percentage is lower than that (33.5 %) 
reported by Walker et al in their study [8]. 
Several other studies have reported incidences 
of medication discrepancies in 14.1–59.6 % of 
patients at discharge [3,4,15,16]. 
 
A variety of factors contributes to the occurrence 
of medication discrepancies. Also, prescribers 
may fail to routinely compare a patient’s inpatient 
medication list to their pre-admission list at the 
time of prescribing and may not communicate 
medication information effectively at the time of 
discharge. Moreover, this study also reported 
that half of counseling pharmacist interventions 
concerned with adding a drug to the treatment 
regimens followed by drug discontinuation (28.1 
%), changing the dose or dose schedule of drug 
and frequency. Furthermore, in an overseas 
study conducted in Iran, adding a drug to the 
treatment regimen (20.9 %) and drug 
discontinuation (19.6 %) were the most frequent 
clinical pharmacist interventions [17]. 
 
In another recently conducted studies in Beirut, it 
has been illustrated that addition of drugs (31 %) 
was one of the common interventions 
recommended by pharmacist [18]. In addition, 
another study suggested that drugs cessation 
was the most recurrent (31.9 %) suggestion 
offered by the intervening pharmacist followed by 
changes in the frequency of administration (21.3 
%) and changes in the drug dose (19.1 %) [19].  
 
Besides, in this study, omissions of medications 
(35 %) were the most common reason for the 
addition of the drug during patient counseling. 
This may happen because of hospital physicians 
forgetting to prescribe drugs used by patients or 
inappropriate medication history review on 
admission and during the hospital stay, which 
often carries over to discharge. Previous studies 
have also shown that omission is the most 
common type of medication discrepancy, with up 
to 61 % of hospitalized patients having at least 
one drug omitted from their regimen [16,20,21]. 
In addition, un-needed medication (14 
%) was the foremost reason associated with drug 
discontinuation. Un-needed medications 
include medications prescribed without clear 
indications or temporary indications and not 
required to be continued with discharge 
medication. Also, a study in a large university 
hospital showed discontinuation of unnecessary 
drugs (22.7 %) as the most common 
interventions suggested by intervening 
pharmacist [22]. 
 
Furthermore, in this study ACEI/ARBS, 
antidiabetic, antihyperlipidemic and antiplatelet 
were the class of drug often associated with 
counseling pharmacist interventions. This finding 
is consistent with the study by Coleman et al. 
who found that angiotensin-converting ezyme 
inhibitors (10 %) and lipid-lowering agents (10 %) 
were among the most common medication 
classes accounted for identified medication 
discrepancies [23]. 
 
The potential financial impact that could result 
from implementation of counseling pharmacist-
provided intervention in this cardiac center was 
also determined. The net cost saving was about 
US $ 9,901.6 per 3 months. If this cost saving 
extrapolates to the whole year, this would be 
equivalent to approximately US $ 39,606.6 per 
year and US $ 198.1 per intervention per year. 
We couldn't compare these results with similar 
studies because of limited studies published in 
this area. However, despite different 
conceptualization, definitions, and methods some 
studies have reported financial impact of 
pharmacist interventions on the cost of drug 
therapy. A study from Thailand reported that 
interventions made by pharmacist resulted in the 
direct cost saving of 1,971.43 US $ over 5 week 
study period [24]. Another study concludes that 
clinical pharmacist had a significant impact on 
the cost of drug therapy as the total net cost 
savings made over a 7 month study period were 
US $ 1796.7 [19]. We encourage further 
research to validate our findings. 
 
The results from this study have important 
inferences for those health care organizations 
that are lacking pharmacist involvement in 
patient counseling at the time of hospital 
discharge. Understanding the type and frequency 
of discrepancies can help clinicians better 
understand ways to prevent them. Also, this 
study identifies a few medications discrepancies 
and highlights some economic consideration. 
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Limitations of the study 
 
The study has limitations in some aspects. 
Medication discrepancies occur at the time of 
admission were not included in the study. Also, 
the interventions carried out by a single 
pharmacist in one hospital and hence the 
findings of this study cannot be generalized to 




Discharge medication discrepancies are common 
in cardiac discharge patients. Pharmacist-
facilitated patient counseling at the point of 
hospital discharge is associated with a 
considerable decrease in the total number of 
discharge medication discrepancies. The most 
common type of intervention identified in this 
study was addition of a drug to the treatment 
regimen due to medication omissions, followed 
by drug discontinuation and change in drug dose. 
This study concludes that pharmacist 
interventions in patient counseling provide a 
substantial cost saving for the specialized 
cardiac center of Saudi Arabia. Additional studies 
are needed to further illustrate the most efficient 
ways to implement discharge counseling and 
establish which elements of the discharge 
process are best targeted to improve clinical 
outcomes and reduce resource utilization. We 
recommend applying such program to all 
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